Journal
NATURE BIOTECHNOLOGY
Volume 31, Issue 9, Pages 844-+Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.2666
Keywords
-
Categories
Funding
- Center for Research on Influenza Pathogenesis, a National Institute of Allergy and Infectious Diseases
- Center of Excellence in Influenza Research and Surveillance [HHSN266200700010C]
- US Army Research Office [W911NF-12-R-0012, W911NF-08-1-0413]
- Burroughs Wellcome Fund
Ask authors/readers for more resources
Recent gain-of-function studies in influenza A virus H5N1 strains revealed that as few as three-amino-acid changes in the hemagglutinin protein confer the capacity for viral transmission between ferrets(1,2). As transmission between ferrets is considered a surrogate indicator of transmissibility between humans, these studies raised concerns about the risks of gain-of-function influenza A virus research. Here we present an approach to strengthen the biosafety of gain-of-function influenza experiments. We exploit species-specific endogenous small RNAs to restrict influenza A virus tropism. In particular, we found that the microRNA miR-192 was expressed in primary human respiratory tract epithelial cells as well as in mouse lungs but absent from the ferret respiratory tract. Incorporation of miR-192 target sites into influenza A virus did not prevent influenza replication and transmissibility in ferrets, but did attenuate influenza pathogenicity in mice. This molecular biocontainment approach should be applicable beyond influenza A virus to minimize the risk of experiments involving other pathogenic viruses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available